LMP2A Immunostaining Results in EBV-Positive and EBV-Negative HD Cases
| HD Type . | EBV-Positive . | EBV-Negative . | ||||
|---|---|---|---|---|---|---|
| . | UK . | Hamburg . | Total . | UK . | Hamburg . | Total . |
| lp | — | — | — | 0/2 | — | 0/2 |
| mc | 6/9 | 7/16 | 13/25 | 0/2* | 0/5 | 0/7 |
| (52%) | ||||||
| ns | 9/14 | 0/1 | 9/15 | 0/15* | 0/11* | 0/26* |
| (60%) | ||||||
| ld | — | — | — | — | 0/2 | 0/2 |
| nt | — | 0/2 | 0/2 | — | 0/2 | 0/2 |
| All | 15/23 | 7/19 | 22/42 | 0/19 | 0/20 | 0/39 |
| (65%) | (37%) | (52%) | ||||
| HD Type . | EBV-Positive . | EBV-Negative . | ||||
|---|---|---|---|---|---|---|
| . | UK . | Hamburg . | Total . | UK . | Hamburg . | Total . |
| lp | — | — | — | 0/2 | — | 0/2 |
| mc | 6/9 | 7/16 | 13/25 | 0/2* | 0/5 | 0/7 |
| (52%) | ||||||
| ns | 9/14 | 0/1 | 9/15 | 0/15* | 0/11* | 0/26* |
| (60%) | ||||||
| ld | — | — | — | — | 0/2 | 0/2 |
| nt | — | 0/2 | 0/2 | — | 0/2 | 0/2 |
| All | 15/23 | 7/19 | 22/42 | 0/19 | 0/20 | 0/39 |
| (65%) | (37%) | (52%) | ||||
Abbreviations: lp, lymphocyte predominant; mc, mixed cellularity; ns, nodular sclerosis; ld, lymphocyte depleted; nt, not typed.
Nonspecific diffuse cytoplasmic staining of HRS cells in a total of 3 EBV-negative cases.